​

CG Oncology (CGON) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

CG Oncology Revenue Highlights

Latest Revenue (Y)

$4.04M

Latest Revenue (Q)

$1.16M

Main Segment (Y)

License And Collaboration Revenue

CG Oncology Revenue by Period

CG Oncology Revenue by Year

DateRevenueChange
2025-12-31$4.04M254.70%
2024-12-31$1.14M458.33%
2023-12-31$204.00K6.81%
2022-12-31$191.00K-98.16%
2021-12-31$10.36M-

CG Oncology generated $4.04M in revenue during NA 2025, up 254.70% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

CG Oncology Revenue by Quarter

DateRevenueChange
2026-06-30$1.16M6.83%
2026-03-31$1.08M-53.36%
2025-12-31$2.32M39.38%
2025-09-30$1.67M100.00%
2025-06-30--100.00%
2025-03-31$52.00K-88.60%
2024-12-31$456.00K960.47%
2024-09-30$43.00K-61.26%
2024-06-30$111.00K-79.02%
2024-03-31$529.00K52800.00%
2023-12-31$1.00K-88.89%
2023-09-30$9.00K100.00%
2023-06-30--100.00%
2023-03-31$194.00K100.00%
2022-12-31--

CG Oncology generated $1.16M in revenue during Q2 2026, up 6.83% compared to the previous quarter, and up 2225.00% compared to the same period a year ago.

CG Oncology Revenue Breakdown

CG Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25
License And Collaboration Revenue$806.00K

CG Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 25: License And Collaboration Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 26Mar 26Dec 25Sep 25Jun 25Mar 25
License And Collaboration Revenue$10.00K$14.00K$648.00K$158.00K--
Operating Segments----$52.00K$52.00K

CG Oncology's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: License And Collaboration Revenue (100.00%).

CG Oncology Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AAPGAscentage Pharma Group$980.65M$141.22K
RAREUltragenyx Pharmaceutical$673.00M$214.00M
TVTXTravere Therapeutics$490.73M$169.58M
TARSTarsus Pharmaceuticals$451.36M$173.91M
LEGNLegend Biotech$285.14M$93.99M
XENEXenon Pharmaceuticals$7.50M-
CGONCG Oncology$4.04M$1.16M
IRONDisc Medicine--
APGEApogee Therapeutics--
CELCCelcuity-$94.00K

CGON Revenue FAQ

What is CG Oncology’s yearly revenue?

CG Oncology's yearly revenue for 2025 was $4.04M, representing an increase of 254.70% compared to 2024. The company's yearly revenue for 2024 was $1.14M, representing an increase of 458.33% compared to 2023. CGON's yearly revenue for 2023 was $204K, representing an increase of 6.81% compared to 2022.

What is CG Oncology’s quarterly revenue?

CG Oncology's quarterly revenue for Q2 2026 was $1.16M, a 6.83% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $1.08M, a -53.36% decrease from the previous quarter (Q4 2025), and a 1982.69% increase year-over-year (Q1 2025). CGON's quarterly revenue for Q4 2025 was $2.32M, a 39.38% increase from the previous quarter (Q3 2025), and a 409.21% increase year-over-year (Q4 2024).

What is CG Oncology’s revenue growth rate?

CG Oncology's revenue growth rate for the last 3 years (2023-2025) was 1880.39%, and for the last 5 years (2021-2025) was -61.00%.

What are CG Oncology’s revenue streams?

CG Oncology's revenue streams in c 25 are License And Collaboration Revenue

What is CG Oncology’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of CG Oncology was License And Collaboration Revenue. This segment made a revenue of $806K, representing 100.00% of the company's total revenue.